Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Qi Wang
 -- 2246 2022-07-28 18:40:11 |
2 Format correction
Sirius Huang
 + 1 word(s) 2247 2022-08-01 03:35:31 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Slater, C.;  Liu, Y.;  Weiss, E.;  Yu, K.;  Wang, Q. The Neuromodulatory Role of the Noradrenergic System. Encyclopedia. Available online: https://encyclopedia.pub/entry/25627 (accessed on 26 December 2024).
Slater C,  Liu Y,  Weiss E,  Yu K,  Wang Q. The Neuromodulatory Role of the Noradrenergic System. Encyclopedia. Available at: https://encyclopedia.pub/entry/25627. Accessed December 26, 2024.
Slater, Cody, Yuxiang Liu, Evan Weiss, Kunpeng Yu, Qi Wang. "The Neuromodulatory Role of the Noradrenergic System" Encyclopedia, https://encyclopedia.pub/entry/25627 (accessed December 26, 2024).
Slater, C.,  Liu, Y.,  Weiss, E.,  Yu, K., & Wang, Q. (2022, July 28). The Neuromodulatory Role of the Noradrenergic System. In Encyclopedia. https://encyclopedia.pub/entry/25627
Slater, Cody, et al. "The Neuromodulatory Role of the Noradrenergic System." Encyclopedia. Web. 28 July, 2022.
The Neuromodulatory Role of the Noradrenergic System
Edit
This entry is adapted from the peer-reviewed paper 10.3390/brainsci12070890

The noradrenergic system is one of four primary neuromodulatory systems. It plays an important function in altering basic synaptic transmission patterns. The groups of neurons responsible for the delivery of the neuromodulators are known as ascending neuromodulatory systems. Norepinephrine (NE) has classically been viewed as a major mediator of arousal that plays an important role in regulating cognition, perception, and sensory processing.

locus coeruleus noradrenergic system norepinephrine neuromodulation

1. Introduction

The central nervous system performs an incredibly large number of continuous computations, the result of which is to efficiently process the external world and execute a relevant response. In the human brain, an estimated 1011 neurons make approximately 1000 average connections to other neurons, forming up to 1014 distinct sites for information transmission. That is likely an order of magnitude higher than the total number of cells in the entire human body [1]. Even this staggering number of physical connections understates the complexity of information handling in the brain. Beyond simple neuron-to-neuron connections, multiple subtypes of glial cells are also known to play a role in synaptic transmission [2][3]. This ever-shifting structural background, across which the flow of information proceeds throughout an individual’s life, is then capable of giving rise to a diverse array of orchestral melodies through the 100+ endogenous substances that play a role in modulating synaptic transmission [4]. Some of these substances, known as neurotransmitters, can act over varying physical distances through their interaction with a much larger number of receptors.
Since the discovery of the first neurotransmitter, acetylcholine, in 1926 by Otto Loewi, there has been an explosion in the identification and understanding of chemical neurotransmission. Conceptually simplified, information transfer occurs in two modes: electrical propagation within neurons or chemical propagation outside neurons. Neurotransmitters are the chemicals that traverse the physical division between cells connecting the postsynaptic cell with information from the presynaptic cell. This is primarily mediated through an array of specific receptors on the postsynaptic cell. For any given neuron, the combination of presynaptic inputs will determine if a message is electrically transcribed and transmitted. If it is transmitted, an action potential will travel down the length of a neuron, resulting in the release of extracellular neurotransmitter onto the dendrites of postsynaptic cells. The substances released are usually tightly regulated and reuptaken or degraded to limit the action of the substance on its target.
Generally, neurotransmitters may have excitatory, inhibitory, and neuromodulatory effects on neurons through the action of their receptors. Excitatory receptors, when activated by corresponding neurotransmitters, result in a membrane depolarization and the propagation of an action potential. Glutamate is the neurotransmitter that predominately mediates excitatory effects through its receptor, which is nearly ubiquitously expressed in all types of neurons and many types of glial cells [5]. Inhibitory receptors exert an opposing effect, with the binding of corresponding neurotransmitters resulting in a membrane hyperpolarization that limits the ability of a neuron to initiate an action potential. In the mature brain, γ-aminobutyric acid (GABA) is the primary neurotransmitter that exerts inhibitory effects on neurons through GABAergic receptors [6]. The interplay between these two competing systems has been studied in a variety of contexts [7][8][9] and provides the foundation for how neurotransmission is thought to occur in the brain. The summation of excitatory and inhibitory inputs at every connection point in the brain determines the direction and pattern of information propagation in complex networks of neurons. The third type of neurotransmitters, known as neuromodulators, add an additional, but important, complexity to this paradigm by altering the balance of transmission on a micro, meso, or macroscale.

2. Anatomical Overview of the Noradrenergic System

2.1. Sources

Noradrenergic projection to the forebrain is exclusively provided by a single source, the locus coeruleus (LC), which is a small, bilateral nucleus located in the pons [10][11][12][13][14]. A complete review of the LC was provided by Poe et al. in 2020 [15], but a brief description is provided here. Traditional investigations of the LC presumed it to be a broadly acting, primarily homogenous source of norepinephrine (NE) with wide implications [10][11][16][17], but more recent research has shown that the LC is composed of many distinct modules with highly specific functional roles throughout the brain [15]. There are two major, complementary theories on how a diffusely projecting single source of norepinephrine can achieve such disparate functional results. The first is that the function of NE release relies on regional differences in postsynaptic receptor distribution and resulting differences in spatiotemporal NE reuptake [18][19][20]. The second is a corollary to the function of the noradrenergic system in the periphery, in which the sympathetic nervous system has discrete efferent limbs that are organ specific but capable of acting in a unified manner [21][22]. In this theory, the LC provides localized neuromodulation to well-defined target regions and spiking is synchronized in highly specific subsets of LC neurons. For a more complete review, see Totah et al., 2019 [23].

2.2. Inputs

An important step in understanding the regional and modular functionality of the LC was achieved through an in-depth characterization of the afferent and efferent projections to and from the LC. The LC itself consists of a small, dense core, where cell bodies are found, and a peri-LC shell in which LC dendrites reside [24][25][26]. There are prominent afferent inputs to the LC core originating from the paragigantocellularis nucleus and the prepositus hypoglossi nuclei—both structures in the rostral medulla [27]. There are also additional inputs from the insular cortex, central nucleus of the amygdala, preoptic area, and the lateral and paraventricular hypothalamic areas [25][28][29]. Cerebellar Purkinje cells and neurons from deep cerebellar nuclei also provide synaptic inputs onto the core of the LC [25].
Although the projections of sensory afferents from the mesencephalic trigeminal sensory nucleus (Me5) [30][31] and the nucleus of tractus solitarius (NTS) [32] to the LC exert influences on cognitive functions [33], an important regulatory component on the core noradrenergic neurons in the LC include the peri-LC afferent innervations. Noradrenergic LC neurons possess long dendrites that pass through the surrounding small nuclei-like regions around the LC, which receive separate inputs from a variety of brain regions, including the prefrontal and infralimbic cortex, the amygdala, and the dorsal raphe nucleus [34]. There are additionally cholinergic, serotonergic, and adrenergic inputs to the peri-LC area, representing potential points of indirect regulation from other neuromodulatory systems [15][29]. The peri-LC zone also gives rise to several GABAergic inputs into the LC [35][36].

2.3. Outputs

The efferent projections from the LC are widespread but nonuniform to the neocortex in both rodents [19] and primates [37][38]. Collateral axons from the LC are distributed in a coordinated fashion to target circuits with a specific function [15][25][39][40][41][42][43]. The efferent projections from the LC travel throughout the brain, providing NE input to the cortex, insula, hippocampus, thalamus, amygdala, and cerebellum. A full review of this system was provided by Schwarz and Luo in 2015 [44]. Though the projections are widespread, the selective activation of specifically patterned noradrenergic neurons is poorly understood and likely involves a complex interplay between inputs into the LC and interacting systems [44]. Nevertheless, it has been shown that genetically distinct groups of noradrenergic neurons project to regionally and functionally specific circuits [45]. Understanding the anatomically distinct efferent circuits underlying specific functional consequences is an ongoing area of research that will likely improve our understanding of the role of the LC in the context of localized function.
As an important aspect of neuromodulation, the LC also directly projects to serotonergic, cholinergic, and dopaminergic nuclei, providing a centralized locus of control over, or feedback with, other neuromodulators [46][47].

3. Role of Norepinephrine in the Brain

3.1. Major Noradrenergic Receptor Subtypes

The noradrenergic system exerts influence over brain function through three receptor classes: α1, α2, and β receptors. Each of these receptors has control over specific processes of neurotransmission and sympathetic nervous system regulation. α1 receptors are members of the adrenoreceptor family, a subset of G-protein coupled receptors [48]. They have been further classified into three distinct subtypes: α1A, α1B, and α1D. Each subreceptor has demonstrated unique quantitative differences in effect [48]. Several experiments have explored the different concentrations of these subtypes throughout the brain. Specifically, it has been shown that α1B was more prominent in the thalamus, lateral amygdaloid nuclei, and cortical laminar areas, while α1A was higher in the entorhinal cortex, amygdala, and general cerebral cortex areas [49]. Furthermore, transgenic mouse experiments have allowed for specific receptors to be knocked out, uncovering that both α1A and α1B have a similar expression throughout the central nervous system, just with different abundances [50]. Around 55% of the brain was shown to express α1A, 35% α1B, and less than 10% was found to express α1D [51][52][53]. The function of α1 receptors is implicated in a variety of cognitive processes and synaptic efficacies. Beginning with synaptic involvement, α1 receptors have been shown to increase the firing frequency of pyramidal and somatosensory neurons of the visual cortex through the protein kinase C signaling (PKC) pathway [54][55]. They have also been implicated in the enhancement of glutamate and acetylcholine release as well as neuronal excitation via PKC pathways, calcium pathways, and excitatory synapses [56][57][58][59][60]. α1 has also been shown to affect non-neuronal function as well, with the modulation of synaptic transmission through astrocytes and glial cells [61][62][63]. With regards to cognitive functions, α1 receptors have been shown to be implicated in memory, motor and motivational behavior, memory retention, and storage, but most of these are associated with general norepinephrine release in the brain [64].
α2 receptors are also a type of G-protein coupled adrenoreceptor, classified into three subtypes: α2A, α2B, and α2C. Specifically, α2 receptors have been implicated in orchestrating the presynaptic inhibition of norepinephrine in the central and peripheral nervous system [65][66][67]. This inhibition is critical for regulation of normal involuntary processes including physiological functions of the heart, vision, and gastrointestinal systems. Using pharmacological agents such as prazosin or oxymetazoline, α2A and α2B receptors have been shown to have significant control over sympathetic outflow and blood pressure [67]. Several other studies have shown α2A receptor agonists enhance both serotonin and norepinephrine release [67]. Interestingly, the abundance of α2 receptor subtypes is much more localized than α1. While literature here is limited, studies have shown that α2B receptors are found almost exclusively in the thalamus, while α2C receptors are found in the olfactory bulb, cerebral cortex, hippocampal formation, and dorsal root ganglia [68].
The final type of noradrenergic receptors, classified as β, are also a G-protein coupled receptor, divided into three subtypes: β1, β2, β3 [67]. There have been studies linking β receptors to synaptic plasticity, with norepinephrine acting on β receptors to dictate synaptic strength in hippocampal neurons, as well as NE released from the locus coeruleus enhancing LTD-related memory processing [69].

3.2. Noradrenergic Involvement in Learning and Decision Making

The noradrenergic system has been implicated in a variety of decision-making paradigms as well as throughout the learning process. Studies using optogenetics, pharmacological agents, and lesioning have brought to light the effect norepinephrine has on cognition and higher-order thought processes. One theory regarding the role of NE in decision making involves the idea of network reset, acting as an “internal interrupt” signal [70][71]. Here, it is explained that the phasic activation of locus coeruleus noradrenergic neurons causes an increase of NE throughout the cortex, invoking cognitive shifts and the potential reorganization of neural networks [72]. This shifted brain state is hypothesized to be better equipped for rapid behavioral adaptation and enhanced decision making [72]. Other theories point out how stimulus-induced firing patterns of the LC are closely attuned to behavioral performance, hypothesized from LC primate recordings in visual discrimination tasks [73]. Similar phasic activation in primates has shown how the LC can respond to specific task-related decisions, modulating NE release and adapting future task-relevant decisions [74], as well as showcasing coordinated activity patterns in cortical networks derived from ascending NE projections [75]. Studies invoking NE release through an agonist have shown enhancements in sensory stimulation, allowing more rapid synaptic plasticity and faster behavioral responses [76].
Several pharmacological experiments have investigated the specific role that α2 receptors play in the decision-making process. Studies using NE antagonists have shown α2A receptor knockout leading to more risk-on behavior, with rats exhibiting greedier decisions [77]. α2A agonists have been proven to enhance the efficiency of working memory and reduce impulsivity in primates [78]. This increased receptor uptake in the prefrontal cortex seems to be part of the shifted network brain state described earlier. The agonist guanfacine, another α2A agent, was also shown to improve visual object discrimination performance during a reversal learning paradigm in primates [79].

3.3. Noradrenergic Involvement in Attention

The noradrenergic modulation of attention has been studied for several decades [80][81][82]. Studies have established the theory that the LC-NE system regulates the efficacy of information processing during neural coding of sensory signals [83][84][85]. During behavioral tasks, selective attention enhances neuronal responsiveness to sensory cues [86][87]. The firing rates of LC neurons are correlated with attentive behavior in an odd-ball task [80], in which either high or low tonic firing rates correspond to inattentive states and medium firing rates are associated with animals’ best performance. In a novel environment where more adaptive behaviors are required, changes in electrotonic coupling among LC neurons regulate goal-directed exploration and preserve attentional selectivity [73]. In addition, some studies have investigated the effects of NE agonists. It is shown that in a cued target detection task (CTD), the application of α2 receptor agonists clonidine or guanfacine significantly impaired alerting behavior, and the effect was dose-dependent [88], while the effect was blocked by the α2 antagonists idazoxan or yohimbine.
Most recent studies also show an association between the NE system and impulsivity control [89][90][91]. It was observed from the superior frontal theta band activity that the NE system dynamically gains and loses relevance to regulate inhibitory control under different responding modes [91]. This work has led to the use of the NE-specific reuptake inhibitor atomoxetine as a treatment of pediatric attention-deficit/hyperactivity disorder (ADHD) [89]. Furthermore, it is demonstrated that ADHD patients have a higher positron emission tomography (PET)-measured NET availability in comparison to healthy individuals, suggesting that there are underlying genetic and epigenetic mechanisms.

References

  1. Bianconi, E.; Piovesan, A.; Facchin, F.; Beraudi, A.; Casadei, R.; Frabetti, F.; Vitale, L.; Pelleri, M.C.; Tassani, S.; Piva, F.; et al. An estimation of the number of cells in the human body. Ann. Hum. Biol. 2013, 40, 463–471.
  2. Newman, E.A. New roles for astrocytes: Regulation of synaptic transmission. Trends Neurosci. 2003, 26, 536–542.
  3. Marinelli, S.; Basilico, B.; Marrone, M.C.; Ragozzino, D. Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission. Semin. Cell Dev. Biol. 2019, 94, 138–151.
  4. Hyman, S.E. Neurotransmitters. Curr. Biol. 2005, 15, R154–R158.
  5. Nedergaard, M.; Takano, T.; Hansen, A.J. Beyond the role of glutamate as a neurotransmitter. Nat. Rev. Neurosci. 2002, 3, 748–755.
  6. Owens, D.F.; Kriegstein, A.R. Is there more to GABA than synaptic inhibition? Nat. Rev. Neurosci. 2002, 3, 715–727.
  7. Kurcyus, K.; Annac, E.; Hanning, N.M.; Harris, A.D.; Oeltzschner, G.; Edden, R.; Riedl, V. Opposite Dynamics of GABA and Glutamate Levels in the Occipital Cortex during Visual Processing. J. Neurosci. 2018, 38, 9967–9976.
  8. Carlsson, A.; Waters, N.; Holm-Waters, S.; Tedroff, J.; Nilsson, M.; Carlsson, M.L. Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence. Annu. Rev. Pharmacol. Toxicol. 2001, 41, 237–260.
  9. Marmigere, F.; Rage, F.; Tapia-Arancibia, L. GABA-glutamate interaction in the control of BDNF expression in hypothalamic neurons. Neurochem. Int. 2003, 42, 353–358.
  10. Grzanna, R.; Molliver, M.E. The locus coeruleus in the rat: An immunohistochemical delineation. Neuroscience 1980, 5, 21–40.
  11. Swanson, L.W.; Hartman, B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 1975, 163, 467–505.
  12. Sara, S.J.; Bouret, S. Orienting and reorienting: The locus coeruleus mediates cognition through arousal. Neuron 2012, 76, 130–141.
  13. Foote, S.L.; Bloom, F.E.; Aston-Jones, G. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity. Physiol. Rev. 1983, 63, 844–914.
  14. Dahlström, A.; Fuxe, K. Demonstration of Monoamines in the Cell Bodies of Brain Stem Neurons; Almqvist & Wiksell: Uppsala, Sweden, 1964.
  15. Poe, G.R.; Foote, S.; Eschenko, O.; Johansen, J.P.; Bouret, S.; Aston-Jones, G.; Harley, C.W.; Manahan-Vaughan, D.; Weinshenker, D.; Valentino, R.; et al. Locus coeruleus: A new look at the blue spot. Nat. Rev. Neurosci. 2020, 21, 644–659.
  16. Fallon, J.H.; Koziell, D.A.; Moore, R.Y. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 1978, 180, 509–532.
  17. Morrison, J.H.; Molliver, M.E.; Grzanna, R.; Coyle, J.T. Noradrenergic innervation patterns in three regions of medial cortex: An immunofluorescence characterization. Brain Res Bull 1979, 4, 849–857.
  18. Berridge, C.W.; Waterhouse, B.D. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 2003, 42, 33–84.
  19. Agster, K.L.; Mejias-Aponte, C.A.; Clark, B.D.; Waterhouse, B.D. Evidence for a regional specificity in the density and distribution of noradrenergic varicosities in rat cortex. J. Comp. Neurol. 2013, 521, 2195–2207.
  20. Giustino, T.F.; Maren, S. Noradrenergic Modulation of Fear Conditioning and Extinction. Front. Behav. Neurosci. 2018, 12, 43.
  21. Jänig, W. Integrative Action of the Autonomic Nervous System: Neurobiology of Homeostasis; Cambridge University Press: Cambridge, UK, 2006.
  22. Farmer, D.G.S.; Pracejus, N.; Dempsey, B.; Turner, A.; Bokiniec, P.; Paton, J.F.R.; Pickering, A.E.; Burguet, J.; Andrey, P.; Goodchild, A.K.; et al. On the presence and functional significance of sympathetic premotor neurons with collateralized spinal axons in the rat. J. Physiol. 2019, 597, 3407–3423.
  23. Totah, N.K.B.; Logothetis, N.K.; Eschenko, O. Noradrenergic ensemble-based modulation of cognition over multiple timescales. Brain Res. 2019, 1709, 50–66.
  24. Shipley, M.T.; Fu, L.; Ennis, M.; Liu, W.-L.; Aston-Jones, G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J. Comp. Neurol. 1996, 365, 56–68.
  25. Schwarz, L.A.; Miyamichi, K.; Gao, X.J.; Beier, K.T.; Weissbourd, B.; DeLoach, K.E.; Ren, J.; Ibanes, S.; Malenka, R.C.; Kremer, E.J.; et al. Viral-genetic tracing of the input-output organization of a central noradrenaline circuit. Nature 2015, 524, 88–92.
  26. Totah, N.K.; Neves, R.M.; Panzeri, S.; Logothetis, N.K.; Eschenko, O. The Locus Coeruleus Is a Complex and Differentiated Neuromodulatory System. Neuron 2018, 99, 1055–1068.e1056.
  27. Aston-Jones, G.; Ennis, M.; Pieribone, V.A.; Nickell, W.T.; Shipley, M.T. The brain nucleus locus coeruleus: Restricted afferent control of a broad efferent network. Science 1986, 234, 734–737.
  28. Cedarbaum, J.M.; Aghajanian, G.K. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 1978, 178, 1–15.
  29. Aston-Jones, G.; Shipley, M.T.; Chouvet, G.; Ennis, M.; van Bockstaele, E.; Pieribone, V.; Shiekhattar, R.; Akaoka, H.; Drolet, G.; Astier, B.; et al. Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology. In Progress in Brain Research; Barnes, C.D., Pompeiano, O., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; Volume 88, pp. 47–75.
  30. De Cicco, V.; Tramonti Fantozzi, M.P.; Cataldo, E.; Barresi, M.; Bruschini, L.; Faraguna, U.; Manzoni, D. Trigeminal, Visceral and Vestibular Inputs May Improve Cognitive Functions by Acting through the Locus Coeruleus and the Ascending Reticular Activating System: A New Hypothesis. Front. Neuroanat. 2018, 11, 130.
  31. Tramonti Fantozzi, M.P.; De Cicco, V.; Argento, S.; De Cicco, D.; Barresi, M.; Cataldo, E.; Bruschini, L.; d’Ascanio, P.; Faraguna, U.; Manzoni, D. Trigeminal input, pupil size and cognitive performance: From oral to brain matter. Brain Res. 2021, 1751, 147194.
  32. Rodenkirch, C.; Carmel, J.; Wang, Q. Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems. Front. Neurosci. 2022, 16.
  33. Tramonti Fantozzi, M.P.; De Cicco, V.; De Cicco, D.; d’Ascanio, P.; Cataldo, E.; Bruschini, L.; Faraguna, U.; Manzoni, D. Chewing and Cognitive Improvement: The Side Matters. Front. Syst. Neurosci. 2021, 15, 158.
  34. Luppi, P.H.; Aston-Jones, G.; Akaoka, H.; Chouvet, G.; Jouvet, M. Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin. Neuroscience 1995, 65, 119–160.
  35. Abrams, P.; Andersson, K.E.; Buccafusco, J.J.; Chapple, C.; de Groat, W.C.; Fryer, A.D.; Kay, G.; Laties, A.; Nathanson, N.M.; Pasricha, P.J.; et al. Muscarinic receptors: Their distribution and function in body systems, and the implications for treating overactive bladder. Br. J. Pharm. 2006, 148, 565–578.
  36. Breton-Provencher, V.; Sur, M. Active control of arousal by a locus coeruleus GABAergic circuit. Nat. Neurosci. 2019, 22, 218–228.
  37. Lewis, D.A.; Morrison, J.H. Noradrenergic innervation of monkey prefrontal cortex: A dopamine-beta-hydroxylase immunohistochemical study. J. Comp. Neurol. 1989, 282, 317–330.
  38. Morrison, J.H.; Foote, S.L. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J. Comp. Neurol. 1986, 243, 117–138.
  39. Kebschull, J.M.; Garcia da Silva, P.; Reid, A.P.; Peikon, I.D.; Albeanu, D.F.; Zador, A.M. High-Throughput Mapping of Single-Neuron Projections by Sequencing of Barcoded RNA. Neuron 2016, 91, 975–987.
  40. Hirschberg, S.; Li, Y.; Randall, A.; Kremer, E.J.; Pickering, A.E. Functional dichotomy in spinal- vs prefrontal-projecting locus coeruleus modules splits descending noradrenergic analgesia from ascending aversion and anxiety in rats. eLife 2017, 6, e29808.
  41. Chandler, D.J.; Gao, W.J.; Waterhouse, B.D. Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices. Proc. Natl. Acad. Sci. USA 2014, 111, 6816–6821.
  42. Zerbi, V.; Floriou-Servou, A.; Markicevic, M.; Vermeiren, Y.; Sturman, O.; Privitera, M.; von Ziegler, L.; Ferrari, K.D.; Weber, B.; De Deyn, P.P.; et al. Rapid Reconfiguration of the Functional Connectome after Chemogenetic Locus Coeruleus Activation. Neuron 2019, 103, 702–718.e705.
  43. Liu, Y.; Rodenkirch, C.; Moskowitz, N.; Schriver, B.; Wang, Q. Dynamic Lateralization of Pupil Dilation Evoked by Locus Coeruleus Activation Results from Sympathetic, Not Parasympathetic, Contributions. Cell Rep. 2017, 20, 3099–3112.
  44. Schwarz, L.A.; Luo, L. Organization of the locus coeruleus-norepinephrine system. Curr. Biol. 2015, 25, R1051–R1056.
  45. Robertson, S.D.; Plummer, N.W.; de Marchena, J.; Jensen, P. Developmental origins of central norepinephrine neuron diversity. Nat. Neurosci. 2013, 16, 1016–1023.
  46. Samuels, E.R.; Szabadi, E. Functional neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr. Neuropharmacol. 2008, 6, 254–285.
  47. Jones, B.E. Noradrenergic locus coeruleus neurons: Their distant connections and their relationship to neighboring (including cholinergic and GABAergic) neurons of the central gray and reticular formation. In Progress in Brain Research; Barnes, C.D., Pompeiano, O., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; Volume 88, pp. 15–30.
  48. Ahlquist, R.P. A study of the adrenotropic receptors. Am. J. Physiol. 1948, 153, 586–600.
  49. Blendy, J.A.; Grimm, L.J.; Perry, D.C.; West-Johnsrud, L.; Kellar, K.J. Electroconvulsive shock differentially increases binding to alpha-1 adrenergic receptor subtypes in discrete regions of rat brain. J. Neurosci. 1990, 10, 2580–2586.
  50. Papay, R.; Gaivin, R.; Jha, A.; McCune, D.F.; McGrath, J.C.; Rodrigo, M.C.; Simpson, P.C.; Doze, V.A.; Perez, D.M. Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. J. Comp. Neurol. 2006, 497, 209–222.
  51. Tanoue, A.; Nasa, Y.; Koshimizu, T.; Shinoura, H.; Oshikawa, S.; Kawai, T.; Sunada, S.; Takeo, S.; Tsujimoto, G. The α1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J. Clin. Investig. 2002, 109, 765–775.
  52. Cavalli, A.; Lattion, A.-L.; Hummler, E.; Nenniger, M.; Pedrazzini, T.; Aubert, J.-F.; Michel, M.C.; Yang, M.; Lembo, G.; Vecchione, C.; et al. Decreased blood pressure response in mice deficient of the α1b-adrenergic receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 11589–11594.
  53. Rokosh, D.G.; Simpson, P.C. Knockout of the α1A/C-adrenergic receptor subtype: The α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc. Natl. Acad. Sci. USA 2002, 99, 9474–9479.
  54. Kobayashi, M.; Kojima, M.; Koyanagi, Y.; Adachi, K.; Imamura, K.; Koshikawa, N. Presynaptic and postsynaptic modulation of glutamatergic synaptic transmission by activation of α1- and β-adrenoceptors in layer V pyramidal neurons of rat cerebral cortex. Synapse 2009, 63, 269–281.
  55. Mouradian, R.D.; Sessler, F.M.; Waterhouse, B.D. Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: Evidence for mediation by an α1 receptor-linked second messenger pathway. Brain Res. 1991, 546, 83–95.
  56. Gordon, G.R.J.; Bains, J.S. Priming of Excitatory Synapses by α1 Adrenoceptor-Mediated Inhibition of Group III Metabotropic Glutamate Receptors. J. Neurosci. 2003, 23, 6223–6231.
  57. Luo, F.; Tang, H.; Li, B.-m.; Li, S.-h. Activation of α1-adrenoceptors enhances excitatory synaptic transmission via a pre- and postsynaptic protein kinase C-dependent mechanism in the medial prefrontal cortex of rats. Eur. J. Neurosci. 2014, 39, 1281–1293.
  58. Velásquez-Martinez, M.C.; Vázquez-Torres, R.; Jiménez-Rivera, C.A. Activation of alpha1-adrenoceptors enhances glutamate release onto ventral tegmental area dopamine cells. Neuroscience 2012, 216, 18–30.
  59. Chen, Q.; Li, D.-P.; Pan, H.-L. Presynaptic α1 Adrenergic Receptors Differentially Regulate Synaptic Glutamate and GABA Release to Hypothalamic Presympathetic Neurons. J. Pharmacol. Exp. Ther. 2006, 316, 733–742.
  60. Marek, G.J.; Aghajanian, G.K. 5-HT2A receptor or α1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur. J. Pharmacol. 1999, 367, 197–206.
  61. Shao, Y.; Sutin, J. Expression of adrenergic receptors in individual astrocytes and motor neurons isolated from the adult rat brain. Glia 1992, 6, 108–117.
  62. Bekar, L.K.; He, W.; Nedergaard, M. Locus Coeruleus α-Adrenergic–Mediated Activation of Cortical Astrocytes In Vivo. Cereb. Cortex 2008, 18, 2789–2795.
  63. Kulik, A.; Haentzsch, A.; Lückermann, M.; Reichelt, W.; Ballanyi, K. Neuron–Glia Signaling via α1 Adrenoceptor-Mediated Ca2+ Release in Bergmann Glial Cells In Situ. J. Neurosci. 1999, 19, 8401–8408.
  64. Perez, D.M. alpha1-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition. Front. Pharm. 2020, 11, 581098.
  65. Trendelenburg, A.U.; Limberger, N.; Rump, L.C. Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex. Mol. Pharmacol. 1994, 45, 1168–1176.
  66. Giovannitti, J.A., Jr.; Thoms, S.M.; Crawford, J.J. Alpha-2 adrenergic receptor agonists: A review of current clinical applications. Anesth. Prog. 2015, 62, 31–39.
  67. Bylund, D.B. Alpha-2 Adrenoceptors. In xPharm: The Comprehensive Pharmacology Reference; Enna, S.J., Bylund, D.B., Eds.; Elsevier: New York, NY, USA, 2007; pp. 1–9.
  68. Philipp, M.; Brede, M.; Hein, L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: One receptor is not enough. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283, R287–R295.
  69. Hagena, H.; Hansen, N.; Manahan-Vaughan, D. β-Adrenergic Control of Hippocampal Function: Subserving the Choreography of Synaptic Information Storage and Memory. Cereb. Cortex 2016, 26, 1349–1364.
  70. Dayan, P.; Yu, A.J. Phasic norepinephrine: A neural interrupt signal for unexpected events. Network 2006, 17, 335–350.
  71. Ego-Stengel, V.; Bringuier, V.; Shulz, D.E. Noradrenergic modulation of functional selectivity in the cat visual cortex: An in vivo extracellular and intracellular study. Neuroscience 2002, 111, 275–289.
  72. Bouret, S.; Sara, S.J. Network reset: A simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci. 2005, 28, 574–582.
  73. Usher, M.; Cohen, J.D.; Servan-Schreiber, D.; Rajkowski, J.; Aston-Jones, G. The Role of Locus Coeruleus in the Regulation of Cognitive Performance. Science 1999, 283, 549–554.
  74. Gold, P.E. Acetylcholine modulation of neural systems involved in learning and memory. NeuroBiol. Learn Mem. 2003, 80, 194–210.
  75. Joshi, S.; Gold, J.I. Context-dependent relationships between locus coeruleus firing patterns and coordinated neural activity in the anterior cingulate cortex. eLife 2022, 11, e63490.
  76. Gu, Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 2002, 111, 815–835.
  77. Montes, D.R.; Stopper, C.M.; Floresco, S.B. Noradrenergic modulation of risk/reward decision making. Psychopharmacology 2015, 232, 2681–2696.
  78. Kim, S.; Bobeica, I.; Gamo, N.J.; Arnsten, A.F.; Lee, D. Effects of alpha-2A adrenergic receptor agonist on time and risk preference in primates. Psychopharmacology 2012, 219, 363–375.
  79. Steere, J.C.; Arnsten, A.F. The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys. Behav. Neurosci. 1997, 111, 883–891.
  80. Aston-Jones, G.; Chiang, C.; Alexinsky, T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog. Brain Res. 1991, 88, 501–520.
  81. Foote, S.L.; Berridge, C.W.; Adams, L.M.; Pineda, J.A. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Prog. Brain Res. 1991, 88, 521–532.
  82. Aston-Jones, G.; Bloom, F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1981, 1, 876–886.
  83. Rodenkirch, C.; Liu, Y.; Schriver, B.J.; Wang, Q. Locus coeruleus activation enhances thalamic feature selectivity via norepinephrine regulation of intrathalamic circuit dynamics. Nat. Neurosci. 2019, 22, 120–133.
  84. Livingstone, M.S.; Hubel, D.H. Effects of sleep and arousal on the processing of visual information in the cat. Nature 1981, 291, 554–561.
  85. McCormick, D.A.; Pape, H.C.; Williamson, A. Actions of norepinephrine in the cerebral cortex and thalamus: Implications for function of the central noradrenergic system. In Progress in Brain Research; Barnes, C.D., Pompeiano, O., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; Volume 88, pp. 293–305.
  86. Mountcastle, V.B.; Andersen, R.A.; Motter, B.C. The influence of attentive fixation upon the excitability of the light- sensitive neurons of the posterior parietal cortex. J. Neurosci. 1981, 1, 1218.
  87. Hyvarinen, J.; Poranen, A.; Jokinen, Y. Influence of attentive behavior on neuronal responses to vibration in primary somatosensory cortex of the monkey. J. Neurophysiol. 1980, 43, 870–882.
  88. Coull, J.T.; Nobre, A.C.; Frith, C.D. The Noradrenergic α2 Agonist Clonidine Modulates Behavioural and Neuroanatomical Correlates of Human Attentional Orienting and Alerting. Cereb. Cortex 2001, 11, 73–84.
  89. Spencer, T.; Biederman, J.; Heiligenstein, J.; Wilens, T.; Faries, D.; Prince, J.; Faraone, S.V.; Rea, J.; Witcher, J.; Zervas, S. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 2001, 11, 251–265.
  90. Sigurdardottir, H.L.; Kranz, G.S.; Rami-Mark, C.; James, G.M.; Vanicek, T.; Gryglewski, G.; Berroterán-Infante, N.; Kautzky, A.; Hienert, M.; Traub-Weidinger, T.; et al. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET. Mol. Psychiatry 2021, 26, 1009–1018.
  91. Dippel, G.; Mückschel, M.; Ziemssen, T.; Beste, C. Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry—Implications for the norepinephrine system during inhibitory control. NeuroImage 2017, 157, 575–585.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Neurosciences
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Cody Slater
,
Yuxiang Liu
,
Evan Weiss
,
Kunpeng Yu
,
Qi Wang
View Times: 562
Revisions: 2 times (View History)
Update Date: 01 Aug 2022
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback